rs1057519043
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000141.5(FGFR2):c.1012G>T(p.Gly338Trp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 11/18 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G338E) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000141.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FGFR2 | NM_000141.5 | c.1012G>T | p.Gly338Trp | missense_variant | 8/18 | ENST00000358487.10 | |
FGFR2 | NM_022970.4 | c.1087+1291G>T | intron_variant | ENST00000457416.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FGFR2 | ENST00000358487.10 | c.1012G>T | p.Gly338Trp | missense_variant | 8/18 | 1 | NM_000141.5 | A2 | |
FGFR2 | ENST00000457416.7 | c.1087+1291G>T | intron_variant | 1 | NM_022970.4 | P4 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
FGFR2-related craniosynostosis Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jul 25, 2018 | This sequence change replaces glycine with tryptophan at codon 338 of the FGFR2 protein (p.Gly338Trp). The glycine residue is highly conserved and there is a large physicochemical difference between glycine and tryptophan. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Variants that disrupt the p.Gly338 amino acid residue in FGFR2 have been observed in affected individuals (PMID: 8946174, 12575301, 23754559, 24127277, 29037998). This suggests that it is a clinically significant residue, and that other variants that disrupt this residue are likely to be causative of disease. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). This variant has been observed to segregate with features of FGFR2-related disease in a family (Invitae). This variant is not present in population databases (ExAC no frequency). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at